These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 38463158)
21. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170 [TBL] [Abstract][Full Text] [Related]
22. Novel vaccine candidates against Mycobacterium tuberculosis. Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365 [TBL] [Abstract][Full Text] [Related]
23. Novel vaccination strategies and approaches against human tuberculosis. Méndez-Samperio P Scand J Immunol; 2019 Aug; 90(2):e12774. PubMed ID: 31054193 [TBL] [Abstract][Full Text] [Related]
24. Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries. Ragonnet R; Trauer JM; Geard N; Scott N; McBryde ES BMC Med; 2019 Nov; 17(1):208. PubMed ID: 31752895 [TBL] [Abstract][Full Text] [Related]
25. What's Old and New in Tuberculosis Vaccines for Children. Cranmer LM; Cotton MF; Day CL; Nemes E J Pediatric Infect Dis Soc; 2022 Oct; 11(Supplement_3):S110-S116. PubMed ID: 36314550 [TBL] [Abstract][Full Text] [Related]
26. A century of attempts to develop an effective tuberculosis vaccine: Why they failed? Soleimanpour S; Yaghoubi A; Sadat Seddighinia F; Rezaee SAR Int Immunopharmacol; 2022 Aug; 109():108791. PubMed ID: 35487086 [TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study. Tseng CL; Oxlade O; Menzies D; Aspler A; Schwartzman K BMC Public Health; 2011 Jan; 11():55. PubMed ID: 21269503 [TBL] [Abstract][Full Text] [Related]
28. Development of tuberculosis vaccines in clinical trials: Current status. Méndez-Samperio P Scand J Immunol; 2018 Oct; 88(4):e12710. PubMed ID: 30175850 [TBL] [Abstract][Full Text] [Related]
29. Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine. Fu H; Lewnard JA; Frost I; Laxminarayan R; Arinaminpathy N Nat Commun; 2021 Jan; 12(1):424. PubMed ID: 33462224 [TBL] [Abstract][Full Text] [Related]
30. Towards new TB vaccines: What are the challenges? Dockrell HM Pathog Dis; 2016 Jun; 74(4):ftw016. PubMed ID: 26960944 [TBL] [Abstract][Full Text] [Related]